key: cord-0991276-er00qbb3 authors: Goyal, A.; Saxena, K.; Kar, A.; Khurana, A.; Pakhare, A. P.; Bhagtana, P. K.; Sridevi, C. S. K. R. title: Obstructive sleep apnea is highly prevalent in COVID19 moderate to severe ARDS survivors: Findings of level I Polysomnography in a tertiary care hospital date: 2021-05-06 journal: nan DOI: 10.1101/2021.05.04.21256593 sha: 394580aad2cdec5d1bb6593d1861d99d8cb45e59 doc_id: 991276 cord_uid: er00qbb3 Study Objectives- Studies have found Obstructive Sleep Apnea (OSA) as a risk factor for increased risk for COVID19 Acute respiratory Distress Syndrome (ARDS); but most of the studies were done in already known patients of OSA. This study was done to find prevalence of OSA in patients with COVID-19 related acute respiratory distress syndrome. Methodology- A hospital based longitudinal study was conducted among COVID 19 Intensive Care Unit (ICU) survivors. All consecutive COVID19 with moderate to severe ARDS were evaluated for OSA by Level I Polysomnography (PSG) after 4-6 weeks of discharge. Prevalence of OSA and PSG variables {Total sleep time, Sleep efficiency, sleep stage percentage, Apnea Hypopnea Index (AHI), T90, nadir oxygen} was estimated. Results- Out of 103 patients discharged from ICU during study period (October 2020 to 15 December 2020), 67 underwent Level I PSG. Mean Age was 52.6 years and mean Body Mass Index was 27.5 Kg/m2. Total sleep time was 343.2 minutes, sleep efficiency was 75.9. OSA (AHI more than 5 ) was seen in 65/67 patients and 49 patients had moderate to severe OSA (i.e. AHI more than 15). Conclusion- Moderate-severe OSA was highly prevalent (73%) in COVID19 moderate to severe ARDS survivors. Role of OSA in pathophysiology of COVID19 ARDS needs further evaluation. COVID-19 has been one of the biggest catastrophe in the history of mankind Till date 100 million people have been infected and more than 2 million have died of this infection. Severity of COVID-19 infection has been attributed to several comorbid conditions like systemic hypertension, diabetes mellitus, coronary artery disease and chronic kidney disease. 1 In an attempt to decipher the pathophysiology and predisposing conditions, researchers are exploring newer avenues . Published articles have also assessed Obstructive Sleep Apnea(OSA) as a probable risk factor for severe COVID-19 disease due to shared pathophysiological pathways. 2,3 A retrospective study which was based on electronic health record has identified OSA as risk factor for mortality in COVID19 ARDS. 4 Moreover the relationship of severity of OSA with that of COVID-19 has not been precisely documented. This study was done to find prevalence of OSA in patients with COVID-19 related moderate to severe Acute respiratory distress syndrome. This is a single centred prospective study conducted at a tertiary care teaching hospital in India. This study was carried over a period of two months (October 2020 to December 2020) on consecutive symptomatic COVID19 related acute respiratory distress syndrome patients who were discharged from ICU or isolation wards. Aim of this study was to find prevalence of OSA in patients with COVID-19 related Acute respiratory distress syndrome. Inclusion Criteria: Patient meeting all the criteria were included: 1. Age ≥ 18 years. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint 2. Patients positive for COVID 19 by RT PCR of nasopharyngeal and oropharyngeal swabs at the time of ICU admission 3. Patients with P/F <200 and fulfils criteria of ARDS. 4 . Patients must not require oxygen support at time of sleep study. 5. Patients must have tested negative COVID 19 (nasopharyngeal swab-RT PCR) at least 3 weeks prior to study Exclusion criteria: 1. Patients who refused to give consent for PSG and participation in study 2. Patients who were not able to sit and stand without support even after 3 weeks of discharge. 3. Patients who required oxygen support after 3 weeks of discharge from ICU. All consecutive patients who were getting discharged from ICU were screened for general condition, maximum oxygen requirement during hospital course and interface of oxygen supplementation were noted. Appointment for polysomnography was allotted after 3 weeks of negative nasopharyngeal and oropharyngeal COVID19 RT PCR report. On the day of PSG, they were again screened for any symptoms suggestive of respiratory infection, fever, throat pain, dyspnea and oxygen requirement prior to sleep study appointment. Patients were enrolled when found fit for study as per inclusion criteria. All demographic parameters, co morbidities, anthropometric parameters, STOP BANG, NoSAS, Berlin questionnaire (BQ) and Epworth Sleepiness Scores (ESS) were recorded prior to study. Questions for . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Ethics review: Approval for ethics approval was taken approval from AIIMS Bhopal Institutional Human Ethics committee (IHEC-LOP/2020/IM309). Patients were counselled regarding purpose of the study and consent was taken from every patient. Data analysis: Data analysis was done using R software 6 and gtsummary 7 packages. We have summarized nominal variables with count and percentage and numerical variables with mean and its standard deviation. We have stratified our data across those who required oxygen and those who required ventilatory support (NIV/HFNC/IMV) . Then we have tested difference in distribution of numerical and categorical variables across these groups by using t-test . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint and Chi-square test respectively. p-value less than 0.05 was considered as statistically significant. Recently few studies have tried to find out possibility of poor outcome in COVID19 with pre-existing OSA. In an electronic health record review, mortality was found to be much higher in patients with known OSA (11.7%) compared to controls (6.9%) with an odds ratio of 1.7923. 4 In all previous done work, association with severity of COVID19 was tried to be found in already known patients of OSA. But it is a known fact that more than 90% of patients with OSA remain undiagnosed. 24 None of patients (in current study) were ever evaluated for OSA before COVID19 infection and yet 73% of them had moderate-severe OSA. In pre-COVID19 era, very few studies were done to evaluate sleep disorders (with level I PSG) in ARDS survivors. In a study done from . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint India, PSG was done in 20 ARDS survivors after 4 weeks of discharge from ICU: 2 had Central Sleep Apnea and one had OSA. 25 In another study from United Kingdom, level I PSG was done immediately after discharge from ICU; out of 15 mechanically ventilated patients, 11 had OSA (AHI≥5) and 9 (60%) had Moderate-severe OSA (AHI≥15). 26 In another study, seven ARDS survivors without previous sleep complaints reported difficulty sleeping 6 months after discharge from hospital. 27 All these seven patients underwent PSG and only one had apnea. Further, N3 and REM sleep was significantly reduced, which was consistent with previous reports. The high prevalence of OSA seen in patients with COVID19 ARDS in our study hints that OSA might be an independent risk factor for poor prognosis in patients with COVID19. To prove this however, PSG should be done in asymptomatic or minimally symptomatic individuals diagnosed with COVID19. Untreated OSA can lead to cardiac complications and persistent symptoms including fatigability, insomnia, which are commonly seen in followup of COVID`19 patients. 28 So in our opinion OSA should be ruled out in COVID19 ARDS survivors with these complaints and if moderatesevere OSA is present, it should be treated with Continuous Positive Airway Pressure (CPAP) therapy. 29, 30 Most important strength of this study is that gold standard level I PSG was done in consecutive ICU survivors. To the best of our knowledge, this is the first study in which PSG was done in COVID19 patients. Important limitations of this study were:1) Presence of OSA could not be determined in patients who died during hospitalisation. This may have . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint resulted in underestimation of prevalence of moderate to severe OSA. Although our previous work have shown increased mortality among those with high risk for OSA (as assessed with OSA screening questionnaires). 23 2) Association between presence of OSA and severity of COVID19 could not be explored owing to inclusion of participants from only ICU. For this, patients with minimal or mild symptoms of COVID19 should have been included in study. However due to resource constraints, we restricted our study to ICU survivors. Participants of this study were patients from ICU only therefore findings should not be generalised to all COVID19 patients. To summarise, moderate-severe OSA is highly prevalent (73%) in COVID19 moderate to severe ARDS survivors and it will be interesting to explore further effect of role of OSA in pathophysiology of COVID19 ARDS. We want to thank Mr Amit Sen, Mr Chetan, Mr Ranjit and Ms Artee for performing polysomnography. AG: Conceptualized, data collection, analysis, patient management and manuscript writing. KS: Data collection, Patient management, manuscript writing Av K: Patient management, Data collection, manuscript writing AK: Patient management, Manuscript writing PKB: Data collection, manuscript writing CSKRS: Data collection, manuscript writing AP: Analysis, manuscript writing Compliance with Ethical Standards: This is a retrospective analysis study and waiver of this study was taken from ethical clearance committee. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 6, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint Figure 1 : Flow chart of enrolment of patients for current study "103 " patients were discharged from ICU 1. "19" patients refused for participation 2. 2 patients required oxygen support at time of sleep study 3. 5 patients were unable to sit or stand without support. 4. 10 Patients lost to follow up. A total of 67 patients were enrolled for study and underwent diagnostic level 1 sleep study. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 6, 2021. ; https://doi.org/10.1101/2021.05.04.21256593 doi: medRxiv preprint Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China OSA as a probable risk factor for severe COVID-19 COVID 19 and OSA: exploring multiple cross-ways American journal of respiratory and critical care medicine. NLM (Medline); 2020 Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine R: A Language and Environment for Statistical Computing Austria: R Foundation for Statistical Computing Presentation-Ready Data Summary and Analytic Result Tables Association of Sleep Disordered Breathing with Mono-Symptomatic Nocturnal Enuresis: A Study among School Children of Central India Nocturic obstructive sleep apnea as a clinical phenotype of severe disease Women with OSA have higher chances of having metabolic syndrome than men: effect of gender on syndrome Z in cross sectional study The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system Obesity and COVID-19: ACE 2, the Missing Tile Diagnosing obstructive sleep apnea patients with isolated nocturnal hypoventilation and defining obesity hypoventilation syndrome using new European Respiratory Society classification criteria: an Indian perspective Is obstructive sleep apnoea syndrome really one of the causes of secondary polycythaemia? Hematology Successful use of tPA for thrombolysis in COVID related ARDS: a case series Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study Association of Obstructive Sleep Apnea and severity of COVID-19: A hospital based observational study. medRxiv Increased Prevalence of Sleep-Disordered Breathing in Adults Sleep after critical illness: Study of survivors of acute respiratory distress syndrome and systematic review of literature Sleep-related breathing disorders following discharge from intensive care Chronic sleep disorders in survivors of the acute respiratory distress syndrome Sleep Neurologists Call It 'COVID-Somnia'-Increased Sleep Disturbances Linked to the Pandemic Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea